Monday, April 9, 2007
A New York Times column reads the fine print of the executive compensation disclosure in some proxy statements and looks for the bottom line of the new SEC rules. Some of the items have been previously reported (like the $415.5 million of Occidental Petroleum's CEO Irani, which includes stock options and deferred stock), some is new -- like the $184,555 paid to Pfizer's independent compensation consultant last year. See NYTimes, More Nuggets on Pay From Proxy Filings. A Wall St. Journal article gives more numbers and offers advice to boards: Ten Ways to Restore Investor Confidence In Compensation.